CompaniesByCap
PETS
PetMed Express Inc. (PETS)
NASDAQ · Healthcare

PetMed Express Inc. Revenue 2016–2026

PetMed Express Inc. annual/quarterly revenue history and growth rate from 2016 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • PetMed Express Inc. revenue for the quarter ending December 31, 2025 was 40.7 M, a 21.75% decrease year-over-year.
  • PetMed Express Inc. revenue for the twelve months ending December 31, 2025 was 188.2 M, a 27.79% decrease year-over-year.
  • PetMed Express Inc. annual revenue for 2026 was 179.0 M, a 21.13% decrease from 2025.
  • PetMed Express Inc. annual revenue for 2025 was 227.0 M, a 17.19% decrease from 2024.
  • PetMed Express Inc. annual revenue for 2024 was 274.1 M, a 10.71% increase from 2023.
  • PetMed Express Inc. annual revenue for 2023 was 247.6 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

PetMed Express Inc. (PETS) — Frequently Asked Questions

PetMed Express Inc. (PETS) is a publicly traded US company. It has a market capitalization of $36M. In fiscal 2026 it reported revenue of $179M and net income of -$57M. Explore PETS's stock price, financial statements, earnings history, margins and key ratios below.

What is PetMed Express Inc.'s market cap?

PetMed Express Inc. (PETS) has a market capitalization of $36M.

What is the PETS stock price?

PETS trades at $1.72 (-0.00% on the day).

How much revenue does PetMed Express Inc. make?

PetMed Express Inc. reported revenue of $179M in fiscal 2026.

Is PETS profitable?

In fiscal 2026, PetMed Express Inc. reported net income of -$57M.